{"id":16039,"date":"2021-04-13T09:19:02","date_gmt":"2021-04-13T09:19:02","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it2\/?page_id=16039"},"modified":"2023-03-27T09:44:42","modified_gmt":"2023-03-27T09:44:42","slug":"ana-apezteguia","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","title":{"rendered":"ANA APEZTEGUIA"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

ANA APEZTEGUIA<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ana a plus de huit ans d’exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets dans l’industrie pharmaceutique.<\/p>

Elle a d’abord rejoint Neuraxpharm en tant que Strategy Associate du CEO. Elle est devenue Chief of Staff apr\u00e8s avoir jou\u00e9 un r\u00f4le cl\u00e9 dans l’int\u00e9gration efficace des diff\u00e9rents services du groupe \u00e0 travers plusieurs pays. Ana est responsable du d\u00e9partement de strat\u00e9gie, de la gestion du portefeuille, des projets et des lancements, de la communication externe, de la responsabilit\u00e9 sociale des entreprises et de l’engagement num\u00e9rique.<\/p>

Elle a d\u00e9velopp\u00e9 sa carri\u00e8re professionnelle en tant que Senior Business and Strategy Consultant chez Capgemini Invent (anciennement Capgemini Consulting), travaillant principalement sur des projets de l’industrie pharmaceutique.<\/p>

Ana d\u00e9tient une licence en g\u00e9nie industriel de l’Universit\u00e9 Polytechnique de Catalogne (UPC), sp\u00e9cialis\u00e9e dans la gestion et l’organisation industrielle, et a obtenu des dipl\u00f4mes d’enseignement sup\u00e9rieur en production de strat\u00e9gies de l’\u00c9cole Nationale Sup\u00e9rieure de Techniques Avanc\u00e9es (ENSTA) de Paris.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d’exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets dans l’industrie pharmaceutique. Elle a d’abord rejoint Neuraxpharm en tant que Strategy Associate du CEO. Elle est devenue Chief of Staff apr\u00e8s avoir jou\u00e9 un r\u00f4le cl\u00e9 dans l’int\u00e9gration efficace des diff\u00e9rents services du groupe \u00e0 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16039","page","type-page","status-publish","hentry"],"yoast_head":"\nANA APEZTEGUIA - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANA APEZTEGUIA\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d’exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets dans l’industrie pharmaceutique. Elle a d’abord rejoint Neuraxpharm en tant que Strategy Associate du CEO. Elle est devenue Chief of Staff apr\u00e8s avoir jou\u00e9 un r\u00f4le cl\u00e9 dans l’int\u00e9gration efficace des diff\u00e9rents services du groupe \u00e0 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-27T09:44:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\",\"name\":\"ANA APEZTEGUIA - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg\",\"datePublished\":\"2021-04-13T09:19:02+00:00\",\"dateModified\":\"2023-03-27T09:44:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00c0 propos de nous\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comit\u00e9 Ex\u00e9cutif\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ANA APEZTEGUIA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ANA APEZTEGUIA - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","og_locale":"fr_FR","og_type":"article","og_title":"ANA APEZTEGUIA","og_description":"https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm ANA APEZTEGUIA Ana a plus de huit ans d’exp\u00e9rience en strat\u00e9gie commerciale et en gestion de projets dans l’industrie pharmaceutique. Elle a d’abord rejoint Neuraxpharm en tant que Strategy Associate du CEO. Elle est devenue Chief of Staff apr\u00e8s avoir jou\u00e9 un r\u00f4le cl\u00e9 dans l’int\u00e9gration efficace des diff\u00e9rents services du groupe \u00e0 […]","og_url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2023-03-27T09:44:42+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia","name":"ANA APEZTEGUIA - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-content\/uploads\/sites\/16\/2023\/03\/ana-apezteguia.jpg","datePublished":"2021-04-13T09:19:02+00:00","dateModified":"2023-03-27T09:44:42+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/16\/2023\/03\/27093937\/ana-apezteguia.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif\/ana-apezteguia#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00c0 propos de nous","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous"},{"@type":"ListItem","position":2,"name":"Comit\u00e9 Ex\u00e9cutif","item":"https:\/\/www.neuraxpharm.com\/ch-fr\/a-propos-de-nous\/comite-executif"},{"@type":"ListItem","position":3,"name":"ANA APEZTEGUIA"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-fr\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=16039"}],"version-history":[{"count":39,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039\/revisions"}],"predecessor-version":[{"id":26870,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/16039\/revisions\/26870"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=16039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}